Echo IQ Limited (EIQ.AX)
ASX · AUD · Healthcare · Health Information Services
A$0.525 (+1.94%) as of
Key statistics
- Market cap
- 388.96M
- Forward P/E
- -31.21
- EPS (TTM)
- -0.0300
- Dividend yield
- 0.00%
- 52-week range
- 0.1875 – 1.8750
- Beta
- 0.45
- Revenue (TTM)
- 92k
- Profit margin
- 0.00%
- Analyst target
- A$0.9125
- Volume
- 5.82M
About Echo IQ Limited
Echo IQ Limited, an artificial intelligence (AI) and medical technology company, engages in the development and application of AI for the cardiac diagnostics sector in Australia. It offers EchoSolv, a machine-learning and AI-based clinical decision support software for use as an adjunct to echocardiography in the assessment of severe aortic stenosis and other cardiovascular conditions. The company has a research collaboration with Mayo Clinic to assess cardiac risk in patients receiving cancer therapy. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. Echo IQ Limited is headquartered in Sydney, Australia.
- Sector
- Healthcare
- Industry
- Health Information Services
- Headquarters
- Sydney, NSW, Australia
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.